NDC 73309-184-03 - Albendazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-184
- Requested NDC
- 73309-184-03
- Package NDCs from labels
- 73309-184-01, 73309-184-02, 73309-184-03
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-09-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albendazole - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-09-21 | BULK INGREDIENT |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albendazole | ALBENDAZOLE | Golden State Medical Supply, Inc. | 8de337eb-92e1-15b5-e053-2a95a90ac4f1 | 2026-07-27 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Edenbridge Pharmaceuticals LLC. | 6c48fd89-cb40-477c-8a78-15cbe0df6faa | 2026-07-10 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Alembic Pharmaceuticals Limited | 3b4945c7-56e9-47ed-a7ac-5078a1a50b85 | 2024-09-13 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Alembic Pharmaceuticals Inc. | 2d6856a3-583e-41d4-b73d-6867cbb9778c | 2024-09-11 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Bryant Ranch Prepack | 74aeb307-b408-47b1-bd8f-fe7eeb844466 | 2024-06-28 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Dr.Reddys Laboratories Inc | 9ac95554-94c9-1f38-8f49-ec11979e4ba4 | 2020-06-10 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Novadoz Pharmaceuticals LLC | 594f7aab-b336-4d6d-b702-a33346c69645 | 2020-02-01 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Amneal Pharmaceuticals of New York LLC | 06b5eefc-0b95-4862-b9b6-770063f2adf0 | 2019-09-30 | Warnings, Adverse reactions | F4216019LN |
| ALBENZA | ALBENDAZOLE | Amneal Pharmaceuticals LLC | 1977a867-0ee1-44c0-8da3-fe59c48699f5 | 2019-09-23 | Warnings, Adverse reactions | F4216019LN |
| Albendazole | ALBENDAZOLE | Actavis Pharma, Inc. | f5c7b8cb-a81f-4b13-b3c4-f6edaf880d3b | 2019-07-31 | Warnings, Adverse reactions | F4216019LN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.